Ascentage Pharma Group International (NASDAQ:AAPG) Research Coverage Started at JPMorgan Chase & Co.

JPMorgan Chase & Co. initiated coverage on shares of Ascentage Pharma Group International (NASDAQ:AAPGFree Report) in a report released on Thursday morning, Marketbeat.com reports. The firm issued an overweight rating on the stock.

Ascentage Pharma Group International Price Performance

AAPG stock opened at $21.65 on Thursday. Ascentage Pharma Group International has a 52 week low of $16.50 and a 52 week high of $22.43.

Ascentage Pharma Group International Company Profile

(Get Free Report)

Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

Further Reading

Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.